137 results
DEFA14A
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Additional proxy soliciting materials
4:59pm
(or to use commercially reasonable best efforts to provide the cost of other comparable coverage if COBRA reimbursement would incur tax penalties … reimbursement would incur tax penalties or violate the law) for twenty-four (24) months, accelerated vesting of all of his outstanding options
8-K
EX-10.1
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
may not provide such COBRA reimbursement without incurring tax penalties or violating any requirement of the law, the Company shall use its commercially … tax penalties or violating any requirement of the law, the Company shall use its commercially reasonable best efforts to provide substantially similar
8-K
EX-10.2
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
reimbursement without incurring tax penalties or violating any requirement of the law, the Company shall use its commercially reasonable best efforts … , however, that if and to the extent that the Company may not provide such COBRA reimbursement without incurring tax penalties or violating any requirement
8-K
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
the cost of other comparable coverage if COBRA reimbursement would incur tax penalties or violate the law) for twelve (12) months, and he may be paid … commercially reasonable best efforts to provide the cost of other comparable coverage if COBRA reimbursement would incur tax penalties or violate
8-K
EX-1.1
1m1 s7tu8187r
1 Feb 24
Corbus Pharmaceuticals Announces Proposed Public Offering
5:27pm
424B5
dmpazz
1 Feb 24
Prospectus supplement for primary offering
5:09pm
424B5
4pi whe9ql
31 Jan 24
Prospectus supplement for primary offering
12:00am